Navigation Links
Brain region that can be stimulated to reduce the cognitive deficits of sleep deprivation identified
Date:2/1/2008

NEW YORK A Columbia University Medical Center research team has uncovered how stimulation of a particular brain region can help stave off the deficits in working memory, associated with an extended sleep deprivation.

Working memory is a specific form of short-term memory that relates to the ability to store task-specific information for a limited timeframe, e.g., where your car is parked in a huge mall lot or remembering a phone number for few seconds before writing it down. It has long been established that cognitive performance, such as working memory, declines with sleep deprivation.

We are excited about the possibilities of using brain stimulation to improve cognitive function, said Bruce Luber, Ph.D., lead author of the paper and an instructor in clinical psychiatry at Columbia University College of Physicians & Surgeons and the New York State Psychiatric Institute. We recently published a study in which we were able to improve the working memory performance of young adults for the first time and this new study extends our findings.

In this research, we were able to non-invasively manipulate a brain network identified by imaging to partially remediate the effects of sleep deprivation using repetitive transcranial magnetic stimulation (rTMS), which has already shown promise in treating depression and other disorders," said Sarah H. Lisanby, M.D., senior author of the study and co-principal investigator of the DARPA grant funding this research. Dr. Lisanby is associate professor of clinical psychiatry and chief of the Brain Stimulation and Therapeutic Modulation Division, at the Columbia University College of Physicians & Surgeons and the New York State Psychiatric Institute.

These findings have important implications for better understanding the neural bases of cognitive decline in the elderly. And the rTMS used in this study may potentially be useful in exploring and treating cognitive deficits due to aging and neurop
'/>"/>

Contact: Elizabeth Streich
eas2125@columbia.edu
212-305-6535
Columbia University Medical Center
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. MITs McGovern Institute researchers awarded $8.5M to study brain basis of autism and dyslexia
2. Easter Seals Launches Nationwide Program for U.S. Service Members and Veterans Deployed to Iraq or Afghanistan with Traumatic Brain Injury
3. Treatment capitalizes on unique qualities of radioisotope to prolong lives of brain tumor patients
4. Drug-Related Images Trigger Brains Reward Center
5. High-Dose Chemo Helps Beat Rare Brain Cancer
6. Newborn brain cells modulate learning and memory
7. Jefferson neurosurgeons using new liquid treatment for wide-neck brain aneurysm
8. Deep Brain Stimulation May Improve Recall
9. Deep brain stimulation may improve memory
10. CSHL scientists make progress in determining how the brain selectively interprets sound
11. Amalgam Fillings Dont Affect Childrens Brain Development, Says Study in ADA Journal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/6/2008)...RNewswire-FirstCall/ -- Volcano Corporation,(Nasda...ring and sales of,products for the diagnosis and t..., today announced the relocation of its corporate ...dova to San Diego. The new corporate,headquarters ...and now,houses corporate executives, marketing, fi...
(Date:10/6/2008)...itary personnel and their family members can take,...ssments, BOSTON, Oct. 6 /PRNewswire-USNewswire/ -...members and their families that are unique and,dif... instances matters get,worse and one problem can t... is wise to check things out to see what is really...
(Date:10/6/2008)...t. 6 /PRNewswire/ -- Today, PARI Pharma GmbH will,...ology that uses single,dose ampoules to control me... a proprietary, unit-dose ampoule that is required... eFlow Technology meets an unmet need by,reducing ...very device,simplifying filling procedures, impro...
(Date:10/6/2008)...two Phase 3 studies presented at the American Coll...(ACG) in Orlando, Fla., demonstrated that TAK-390M...le among patients with more severe grades of erosi...azole with a Dual Delayed Release (DDR) formulatio...ug for extended duration of acid suppression. , ...
Breaking Medicine News(10 mins):Health News:Volcano Corporation Announces the Relocation of Corporate Headquarters to San Diego 2Health News:Volcano Corporation Announces the Relocation of Corporate Headquarters to San Diego 3Health News:Volcano Corporation Announces the Relocation of Corporate Headquarters to San Diego 4Health News:Many Military Installations Worldwide Participate in National Depression Screening Day 2Health News:Many Military Installations Worldwide Participate in National Depression Screening Day 3Health News:PARI Pharma Unveils Closed System Using eFlow Technology at Medical Plastics Conference 2Health News:Takeda's investigational PPI TAK-390MR demonstrated higher healing rates compared to lansoprazole 2
... found that radiant-light therapy may be an effect.... Dan Oren, an associate professor of psychiatry a...hat the availability of an easy-to-use, potentiall...py in pregnancy is a clinically attractive option....
...he University of Michigan, have found a gene which... cancer. Using a technique called DNA microarray a...y of thousands of different genes in tissue sample...CoA racemase (AMACR) and it's never before been se...
...ew study, fibrin, a protein that helps form blood ...ir of nerve damage. The discovery could lead to ne... system, such as multiple sclerosis, although the...e level.// In multiple sclerosis, the slow destruc...
...at standing under a tree affords complete protecti...sity. When the sun comes out, it's pleasant to sit...protecting you from the sun. But don't take the sh...urdue University in the US.// They've built a mat...
Other Medicine News:Health News:Clotting Protein plays a role in nerve repair 2
(Date:10/6/2008)... "A return to the use of,chimpanzees in AIDS resea...justification," according to a paper released toda...s (ATLA). "An Assessment of the Role of,Chimpanzee... responses in,chimpanzees are not predictive of re... critical role and importance in AIDS vaccine deve...
(Date:10/6/2008)...to Improve Patient Safety, WASHINGTON, Oct. 6 /PR...rdiology in collaboration with the American Colleg...iation today released consensus guidelines,outlini...cers and,gastrointestinal (GI) bleeding among pati...SAIDs) along with antiplatelet agents., Gastroint...
(Date:10/6/2008)...-FirstCall/ -- Genaera,Corporation (Nasdaq: GENR ...ical trial of trodusquemine (MSI-1436), Genaera,s ...abetes and obesity. MSI-1436 is a novel,inhibitor ...ls the function,of both the leptin and insulin pat...In the study, MSI-1436 was found to be well-tolera...
(Date:10/6/2008)... Naltrexone SR Associated with Bett...t. 6 /- Orexigen Therapeuti...pany focused on the treatment of,obesity and other...resented,data showing the investigational drug, Co...ully achieved key objectives (lowered naltrexone,C...
Breaking Medicine Technology:Research Attributes Lack of HIV/AIDS Vaccine to Use of Chimpanzees 2Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use 2Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use 3Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use 4Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 2Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 3Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 4Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 2Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 3Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 4Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 5Genes May Play Role in Quitting Smoking 20998 1Genes May Play Role in Quitting Smoking 20998 2Genes May Play Role in Quitting Smoking 20998 3Milestone Scientific Expands Global Distribution Network 20994 1Milestone Scientific Expands Global Distribution Network 20994 2Milestone Scientific Expands Global Distribution Network 20994 3Michael J Fox Foundation for Parkinsons Research Commits up to 242 million to Visualize Alpha Synuclein Protein in the Brain 20990 1Michael J Fox Foundation for Parkinsons Research Commits up to 242 million to Visualize Alpha Synuclein Protein in the Brain 20990 2Michael J Fox Foundation for Parkinsons Research Commits up to 242 million to Visualize Alpha Synuclein Protein in the Brain 20990 3VH1 to Televise The 46664 Concert Honouring Nelson Mandela at 90 Exclusively in the U S 20986 1VH1 to Televise The 46664 Concert Honouring Nelson Mandela at 90 Exclusively in the U S 20986 2VH1 to Televise The 46664 Concert Honouring Nelson Mandela at 90 Exclusively in the U S 20986 3VH1 to Televise The 46664 Concert Honouring Nelson Mandela at 90 Exclusively in the U S 20986 4
...A, Calif.--(BUSINESS WIRE)--Apr 3, 2007 - Calando,...any and a,majority-owned subsidiary of Arrowhead R...blication of a study demonstrating,the anti-prolif...he,therapeutic component of its lead anti-cancer c...RNA Inhibitors of Ribonucleotide,Reductase Subunit...
...ime Reduced By an Average of More Than Two Hours P...07 /PRNewswire/ --,Adding the once daily, investig...4-Hour(TM) Extended-Release Tablets to,Parkinson,s...ificantly reduced ,off, time, allowing patients to...od of time. ,Off time,describes the return of Par...
Other Medicine Technology:Calando Pharmaceuticals Publishes Study Showing Anti-Cancer Effect,with Lead RNAi Candidate 2Calando Pharmaceuticals Publishes Study Showing Anti-Cancer Effect,with Lead RNAi Candidate 3Calando Pharmaceuticals Publishes Study Showing Anti-Cancer Effect,with Lead RNAi Candidate 4Once Daily, Extended-Release Ropinirole Improves Parkinson's,Symptoms in Patients not Optimally Controlled With Levodopa 2Once Daily, Extended-Release Ropinirole Improves Parkinson's,Symptoms in Patients not Optimally Controlled With Levodopa 3Once Daily, Extended-Release Ropinirole Improves Parkinson's,Symptoms in Patients not Optimally Controlled With Levodopa 4Once Daily, Extended-Release Ropinirole Improves Parkinson's,Symptoms in Patients not Optimally Controlled With Levodopa 5
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Deflected large type, opening width 7.0 mm and length 5 mm.
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Deflected large type, opening width 7.0 mm and length 5 mm.
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Deflected large type, opening width 8.0 mm and length 5 mm.
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Deflected large type, opening width 8.0 mm and length 5 mm.
Medicine Products: